Skip to main content
. 2020 Mar 3;87(5):1055–1063. doi: 10.1093/neuros/nyaa009

TABLE 3.

Univariate Adjusted Cox Regression Models of Time to Relapse From Validation Phase for Each Measured miRNA

All patients Patients after total resection
Factor HR 1/HR 95% Cl range P value Factor HR 1/HR 95% Cl range P value
miR-146a-5p based model
Age at diagnosis 0.99 1.01 0.97 1.01 .436 Age at diagnosis 1.01 0.99 0.98 1.04 .709
Sex: male 1.68 0.59 0.84 3.37 .142 Sex: male 1.15 0.87 0.47 2.82 .759
WHO grade 1.63 0.61 1.07 2.50 .024 WHO grade 1.86 0.54 1.06 3.24 .029
Nonconvex. location 0.63 1.60 0.33 1.18 .148 Nonconvex. location 0.54 1.85 0.23 1.25 .150
Partial resection 3.16 0.32 1.67 6.00 4.24E-04
miR-146a-5p 1.34 0.74 1.10 1.63 .003 miR-146a-5p 1.37 0.73 1.07 1.76 .014
miR-15a-5p based model
Age at diagnosis 0.99 1.01 0.97 1.01 .254 Age at diagnosis 0.99 1.01 0.97 1.02 .656
Sex: male 2.77 0.36 1.45 5.27 .002 Sex: male 1.69 0.59 0.72 3.95 .228
WHO grade 1.37 0.73 0.91 2.08 .132 WHO grade 1.85 0.54 1.07 3.18 .027
Nonconvex. location 0.69 1.46 0.37 1.28 .236 Nonconvex. location 0.65 1.55 0.28 1.50 .310
Partial resection 3.67 0.27 1.92 7.02 8.52E-05
miR-15a-5p 0.94 1.06 0.84 1.05 .283 miR-15a-5p 0.96 1.04 0.82 1.11 .573
miR-331-3p based model
Age at diagnosis 1.00 1.00 0.97 1.02 .827 Age at diagnosis 1.01 0.99 0.98 1.04 .443
Sex: male 1.43 0.70 0.67 3.03 .354 Sex: male 1.12 0.89 0.44 2.87 .811
WHO grade 1.33 0.75 0.86 2.05 .200 WHO grade 1.53 0.65 0.86 2.73 .146
Nonconvex. location 0.58 1.72 0.31 1.10 .095 Nonconvex. location 0.46 2.17 0.19 1.11 .085
Partial resection 3.87 0.26 2.03 7.38 4.11E-05
miR-331-3p 1.45 0.69 1.17 1.79 .001 miR-331-3p 1.43 0.70 1.10 1.87 .007

Significant factors are marked in bold.